Clinical Trial Update: Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating daptomycin combined with rifampin for treating staphylococcal prosthetic joint infections; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Joint Infection
• Staphylococcal Infection

Drugs mentioned

• Daptomycin (daptomycin)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Andrej Trampuz | Conditions: Staphylococcal Infections | Phase 2 | Status: UNKNOWN